Sponsor: 
Sanofi-Aventis Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Quadrivalent meningococcal vaccines

Registered for use in people aged 9 months to 55 years.

MenACWY-D — quadrivalent meningococcal (serogroups A, C, W-135, Y)–diphtheria toxoid conjugate vaccine

Each 0.5 mL monodose vial contains:

  • 4 µg meningococcal polysaccharide serogroup A
  • 4 µg meningococcal polysaccharide serogroup C
  • 4 µg meningococcal polysaccharide serogroup W-135
  • 4 µg meningococcal polysaccharide serogroup Y
  • 48 µg diphtheria toxoid protein

The product information and consumer medicine information for Menactra have more details.

Audience: 
Infants and children
Previous

M-M-R II

Next

Menitorix

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018